Anthem Biosciences Limited IPO
Anthem Biosciences Limited is a global innovation-led CRDMO (Contract Research, Development and Manufacturing Organization) offering integrated services across the drug development lifecycle. With expertise in both New Chemical Entities (NCEs) and New Biological Entities (NBEs), the company supports biotech and pharma clients through discovery, development, and commercial manufacturing. Its platform spans five modalities—RNAi, ADCs, peptides, lipids, and oligonucleotides—and four manufacturing capabilities: custom synthesis, flow chemistry, fermentation, and biotransformation. Revenue is primarily driven by CRDMO services, with additional income from specialty ingredient sales.
Price Band₹540 - ₹570 |
Dates14 Jul - 16 Jul |
GMP₹94 (16.49%) |
Subscriptions- |
Issue Size₹3,395.00 Crs |
Anthem Biosciences IPO Objects
The issue is a complete Offer for Sale (OFS). The company will not receive any funds from the issue, entire proceeds will be received by the Selling Shareholder(s).
Selling Shareholders:
- Ganesh Sambasivam (Promoter): 350 Cr
- K Ravindra Chandrappa (Promoter): 350 Cr
- Viridity Tone LLP (Investor): 1,325 Cr
- Portsmouth Technologies LLC (Investor): 320 Cr
- Others: 1,050 Cr
Anthem Biosciences IPO Details
Price Band₹540 - ₹570 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹0.00 (0.00 Shares) |
Offer For Sale₹3,395.00 Cr (5.96 Cr Shares) |
Total Issue₹3,395.00 Cr (5.96 Cr Shares) |
Face Value₹2 per equity share |
Anthem Biosciences IPO Lot Information
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Retail |
Minimum
1
26
14,820
Maximum
13
338
1,92,660
|
|||
| Small HNI |
Minimum
14
364
2,07,480
Maximum
67
1,742
9,92,940
|
|||
| Big HNI |
Minimum
68
1,768
10,07,760
|
|||
Anthem Biosciences IPO GMP
The estimated Grey Market Premium of Anthem Biosciences IPO is ₹94 per share (16.49%)
Category Allocation
| Particulars | Allocation |
|---|---|
| QIBs | Not more than 50% of Net Offer |
| Big HNIs (NII) | Not less than 10% of Net Offer |
| Small HNIs (NII) | Not less than 5% of Net Offer |
| Retail | Not less than 35% of Net Offer |
| Employee | TBT |
Anthem Biosciences IPO Financials
| Particulars | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Revenue from Operations | 1,844.55 | 1,419.37 | 1,056.92 |
| Profit after Tax | 450.86 | 367.06 | 385.94 |
| Net Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Total Borrowing | 108.95 | 232.53 | 125.06 |
| Total Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| NAV per share (in ₹) | 43.10 | 34.43 | 30.51 |
| EPS - Basic (in ₹) | 8.07 | 6.48 | 6.75 |
The financial information presented is on a consolidated basis.
Key Performance Indicators
| KPI | Values |
|---|---|
| EBITDA | 36.81% |
| PAT | 23.38% |
| ROE | 20.82% |
| PE Ratio | 70.63 |
| PB Ratio | 13.23 |
| Mkt Cap (in Crs.) | 32,011.77 |
- All the data pertains to FY 2024-25.
- PE, PB, and market capitalization are calculated based on the Upper Price Band.
Anthem Biosciences IPO Peer Comparision
| Particulars | Anthem Biosciences | Syngene International | Sai Life Sciences | Cohance Life sciences | Divi’s Laboratories |
|---|---|---|---|---|---|
| Revenue from Ops (in Crs.) | 1,844.55 | 3,642.40 | 1,694.57 | 1,197.58 | 9,360.00 |
| PAT (In Crs.) | 451.26 | 496.20 | 170.13 | 264.77 | 2,191.00 |
| EPS - Basic | 8.07 | 12.35 | 8.83 | 10.52 | 82.53 |
| NAV per share | 43.10 | 117.42 | 102.12 | 72.31 | 564.87 |
| RONW | 20.82% | 11.05% | 10.96% | 13.61% | 15.35% |
| EBITDA | 36.81% | 28.60% | 23.94% | 31.33% | 31.71% |
| PAT Margin | 23.38% | 13.36% | 9.83% | 21.08% | 22.56% |
| Price to earning (PE) | 70.63 | 51.54 | 92.18 | 97.29 | 83.22 |
- All information pertains to FY 2024-25.
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of July 7, 2025 for Peers
Anthem Biosciences IPO Peer Comparision
| Particulars | Anthem Biosciences |
|---|---|
| Revenue from Ops (in Crs.) | 1,844.55 |
| PAT (In Crs.) | 451.26 |
| EPS - Basic | 8.07 |
| NAV per share | 43.10 |
| RONW | 20.82% |
| EBITDA | 36.81% |
| PAT Margin | 23.38% |
| Price to earning (PE) | 70.63 |
| Syngene International | Sai Life Sciences | Cohance Life sciences | Divi’s Laboratories |
|---|---|---|---|
| 3,642.40 | 1,694.57 | 1,197.58 | 9,360.00 |
| 496.20 | 170.13 | 264.77 | 2,191.00 |
| 12.35 | 8.83 | 10.52 | 82.53 |
| 117.42 | 102.12 | 72.31 | 564.87 |
| 11.05% | 10.96% | 13.61% | 15.35% |
| 28.60% | 23.94% | 31.33% | 31.71% |
| 13.36% | 9.83% | 21.08% | 22.56% |
| 51.54 | 92.18 | 97.29 | 83.22 |
- All information pertains to FY 2024-25.
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of July 7, 2025 for Peers
Promoter Details
| Name | Shareholding |
|---|---|
| Ajay Bhardwaj | 42.53% |
| Ishaan Bhardwaj | 10.16% |
| Ganesh Sambasivam | 9.23% |
| K Chandrappa | 8.86% |
| Other Promter | 6.10% |
| Total | 76.88% |
Management Details
| Name | Designation |
|---|---|
| Ajay Bhardwaj | Chairman , MD & CEO |
| Mohammed Baig | CFO |
Company Details
Name: Anthem Biosciences Limited
Address: No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Bommasandra, Bangalore, Karnataka, India, 560 099
Number: +91 080 6672 4000
Email: investors.abl@anthembio.com
Website: www.anthembio.com
Book Running Lead Managers (BRLMs)
Citigroup Global
Visit Website
J.P. Morgan
Visit Website
JM Financial
Visit Website
Nomura Financial
Visit WebsiteRTAs
KFin Technologies
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Anthem Biosciences IPO is a Mainboard IPO having an issue size of Rs. ₹3,395.00 Crs. Anthem Biosciences IPO is priced at ₹540 - ₹570 per share. The issue opens on 14 Jul 25 and closes on 16 Jul 25.
Anthem Biosciences IPO opens on 14 Jul 25 and closes on 16 Jul 25.
The estimated Grey Market Premium of Anthem Biosciences IPO is ₹94 per share (16.49%).
The minimum lot size of Anthem Biosciences IPO is 26 shares & the minimum application amount is Rs. 14820.
The allotment date of Anthem Biosciences IPO is 17 Jul 25.
The listing date of Anthem Biosciences IPO is 21 Jul 25.
Anthem Biosciences IPO is subscribed -.
Anthem Biosciences IPO is priced at ₹540 - ₹570 per share.
Click the allotment link on Anthem Biosciences IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Anthem Biosciences IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
We are a one-stop destination for all your IPO needs. Get reliable, accurate, and timely information for all the IPOs in India!